Event Highlights
News from Bayer
March 23, 2023
Not intended for U.S. and UK Media
Bayer expands global clinical program for darolutamide in prostate cancer
March 21, 2023
UN 2023 Water Conference:
Bayer pledges to help tackle global water crisis with new water strategy
March 20, 2023
Not intended for U.S. and UK Media
Nubeqa™ (darolutamide) approved for additional prostate cancer indication in China
Discover More Investor Resources
